Development and Clinical Transformation of Biological Markers for Predicting Acute Leukemia Relapse: A Prospective Cohort Study of Multiple Indicators for Predicting Acute Leukemia Relapse

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300077354

Enrollment

Unknown

Registered

2023-11-06

Start date

2023-11-10

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Leukemia

Interventions

Case series:NA

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Patients with newly diagnosed acute leukemia; 2.Aged 18 to 60 years.

Exclusion criteria

Exclusion criteria: 1.Subjects who cannot receive induction chemotherapy; 2.Subjects who cannot comply with the study.

Design outcomes

Primary

Measure	Time frame
Relapse rate;	—

Secondary

Measure	Time frame
Leukemia-free survival;Overall survival;Non-relapse mortality/Transplantation-related mortality;Acute/ chronic graft-versus-host disease ;	—

Countries

China

Contacts

Public ContactChang Yingjun

Peking University People's Hospital & Peking University Institute of Hematology

rmcyj@bjmu.edu.cn+86 10 8832 5949

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026